Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001615774-17-000876

10% owner sold 425,000 shares at an average $30.82 ($13,098,000)

From the SEC's structured data for this filing

Trades in this filing

VIVO VENTURES VII, LLC · 10% owner

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2017-02-28 Sale : show line 1 in the form −195,734 $30.50 $5,969,887 3,017,798 I
2017-02-28 Sale : show line 2 in the form −4,266 $30.50 $130,113 65,771 I
2017-03-01 Sale : show line 3 in the form −97,867 $30.98 $3,031,920 2,919,931 I
2017-03-01 Sale : show line 4 in the form −2,133 $30.98 $66,080 63,638 I
2017-03-02 Sale : show line 5 in the form −122,334 $31.20 $3,816,821 2,797,597 I
2017-03-02 Sale : show line 6 in the form −2,666 $31.20 $83,179 60,972 I
Open-market sales · 425,000 sh · avg $30.82 · $13,098,000
Loading xslF345X03/s105466_form4.xml…